Local Effects of Acupuncture and Nerve Conduction Studies

October 5, 2023 updated by: Alexandra Dimitrova, Oregon Health and Science University

Local Effects of Acupuncture on the Median and Ulnar Nerves in Patients With Carpal Tunnel Syndrome

Thus study aims to characterize the local, nerve-specific effects of acupuncture on the median and ulnar nerves in the forearm, using nerve conduction studies and quantitative sensory testing. All participant will have carpal tunnel syndrome and the affected median nerve will be compared to the healthy ulnar nerve. Additionally, we aim to compare the local, nerve-specific effect of manual acupuncture to that of low-frequency electroacupuncture and of high-frequency electroacupuncture.

Study Overview

Detailed Description

The purpose of this study is to measure the local effects of acupuncture on the median and ulnar nerves in patients with median neuropathy at the wrist (carpal tunnel syndrome), using nerve conduction studies (NCS) and quantitative sensory testing (QST) as outcomes. Our secondary aim is to compare acupuncture's effect on the functioning of a diseased nerve (median nerve in CTS) to its effect on a healthy nerve (ulnar). Additionally, we aim to compare the local, nerve-specific effect of manual acupuncture to that of low-frequency electroacupuncture and of high-frequency electroacupuncture.

In a mechanistic study of acupuncture, 60 subjects with carpal tunnel syndrome (CTS) will be randomized to manual acupuncture (MA), low-frequency electroacupuncture (LF-EA) and high-frequency electroacupuncture (HF-EA) groups. Baseline measurements will consist of QST (vibration and cold detection thresholds), as well as NCS of both median and ulnar nerves. Then, each group will undergo acupuncture to the median nerve (Pericardium channel points) and to the ulnar nerve (Heart channel points), one week apart, order counterbalanced, followed by post-acupuncture NCS and QST measurements in both nerves' territories.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oregon
      • Portland, Oregon, United States, 97239
        • Oregon Health & Science University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Presence of mild-moderate sensorimotor or sensory median neuropathy, established by pre-existing NCS/EMG study AND
  • Baseline NCS study within the past 2 years, consistent with mild-moderate median entrapment neuropathy (CTS) defined as meeting any of the 3 conditions below:

    1. Prolonged distal Median sensory AND/OR motor latency
    2. Reduced Median sensory nerve action potentials (SNAP) amplitude by no more than 50%
    3. Amplitude of the compound muscle action potential (CMAP) recorded from APB > 50% of normal
  • Presence of neuropathy symptoms consistent with CTS for at least 3 months

Exclusion Criteria:

Conditions in which acupuncture/electroacupuncture may be contraindicated:

  • Coagulopathy/ Current anti-coagulation treatment
  • Epilepsy
  • History of CAD or pacemaker insertion
  • Pregnancy
  • Presence of any skin condition in the arm, such as dermatitis, bruises, weeping skin, skin lesions, infected skin, or necrotic skin.

Conditions in which QST testing may be contraindicated:

  • Significant cognitive impairment such as diagnosis of Alzheimer's disease or Mental Retardation or any other condition interfering with alertness, attention and ability to participate in QST
  • Hospitalization for anxiety or depression in the past 3 months
  • Current psychiatric diagnoses (other than anxiety or depression)
  • Illicit drug use in the past month
  • Current EtOH abuse (> 2 drinks/day)
  • History of significant neurological disease which may affect sensation, e.g., strokes, Multiple Sclerosis, or spinal cord disorder
  • Change in neuropathy medications within the past 2 months
  • Change in opioid, benzodiazepines, SSRIs or other sedating medications in the past 2 months

Conditions, which predispose to generalized neuropathy

  • Abnormal thyroid function tests (by history)
  • Past chemotherapy treatment

Other Contraindications:

  • History of wrist or elbow fracture, past arm trauma, loss of fingers, scarring
  • History of carpal tunnel release surgery or any other surgery on the arm or shoulder
  • History of arthritis
  • Use of any investigational drugs within the previous six months

Exclusion Criteria based on NCS within the past 2 years:

  • Presence of isolated motor Median neuropathy (absence of sensory neuropathy on NCS or absence of sensory symptoms)
  • Severe neuropathy symptoms leading to inability to tolerate acupuncture or QST
  • Presence of Severe Carpal Tunnel Syndrome, defined as:

    1. Absent sensory nerve action potential recorded from the second or fifth digit.
    2. The amplitude of the compound muscle action potential recorded from the APB or ADM is less than 50% of normal (< 2.5 mv)
  • Presence of Ulnar neuropathy
  • Presence of Martin-Gruber anastomosis

Secondary Exclusion Criteria after WEEK 1 Baseline QST and NCS measurements:

  • Failure to comply with QST due to inattentiveness, etc
  • Hyperalgesia on QST
  • Hypoalgesia on QST
  • Inability to confirm diagnosis of mild-moderate CTS (normal NCS)
  • Inability to tolerate NCS/QST
  • Presence Severe CTS
  • Pure Motor Median Neuropathy
  • Ulnar Neuropathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Manual Acupuncture

Device:

Sterile single-use MAC acupuncture needles - 0.22 x 25 mm, TianJin Haing Lim Sou Won Medical Equipment Co, Ltd, South Korea

Used for Intervention:

Manual Acupuncture to PC3, PC5 or HT3, HT4 for 20 min

Sterile single-use MAC acupuncture needles (0.22 x 25 mm, TianJin Haing Lim Sou Won Medical Equipment Co, Ltd, South Korea. Used for Manual Acupuncture

Used for: Manual Acupuncture to PC3, PC5 or HT3, HT4 for 20 min

Experimental: Low-Frequency Electroacupuncture

Device:

Electrostimulator 6c.Pro, Pantheon Research, Venice, CA

Used for Intervention:

Low-frequency Continuous Electroacupuncture (2Hz) to PC3, PC5 or HT3, HT4 for 20 min

Electrostimulator used for delivery or Low-Frequency or High-Frequency Electroacupuncture

Used for Interventions:

Low-frequency Continuous Electroacupuncture to PC3, PC5 or HT3, HT4 for 20 min AND High-frequency Continuous Electroacupuncture to PC3, PC5 or HT3, HT4 for 20 min

Experimental: High-Frequency Electroacupuncture

Device:

Electrostimulator 6c.Pro, Pantheon Research, Venice, CA

Used for Intervention:

High-frequency Continuous Electroacupuncture (100 Hz) to PC3, PC5 or HT3, HT4 for 20 min

Electrostimulator used for delivery or Low-Frequency or High-Frequency Electroacupuncture

Used for Interventions:

Low-frequency Continuous Electroacupuncture to PC3, PC5 or HT3, HT4 for 20 min AND High-frequency Continuous Electroacupuncture to PC3, PC5 or HT3, HT4 for 20 min

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Median Cold Detection Threshold (CDT) Post-acupuncture Compared to Pre-acupuncture When the Median Nerve is Treated
Time Frame: Week 1, Week 2

The median change plus standard deviation when the median nerve was treated and CDT was measured in the sensory distribution of the median nerve.

The CDT is measured in CASE IV - specific units named Just Noticeable Difference (JND). The CASE IV System uses a set of 25 standardized vibratory and thermal stimulation levels for patient testing and analysis. These 25 levels are termed "Just Noticeable Differences" or "JNDs," and are similar to decibels. The concept of a JND is based on the fact that a sensitive person can detect fine differences between two levels of stimulation, whereas an insensitive person cannot. Because differences of less than one JND are difficult to distinguish, one JND is the smallest difference presented to patients. Stimuli based on the JND scale can be used to test patients very efficiently and quickly, without compromising the significance of the clinical result.

Week 1, Week 2
Change in Ulnar Cold Detection Threshold (CDT) Post-acupuncture Compared to Pre-acupuncture When the Median Nerve is Treated
Time Frame: Week 1, Week 2

This is the mean change plus standard deviation in CDT in the sensory distribution of the ulnar never when the median nerve is treated.

The CDT is measured in CASE IV - specific units named Just Noticeable Difference (JND). The CASE IV System uses a set of 25 standardized vibratory and thermal stimulation levels for patient testing and analysis. These 25 levels are termed "Just Noticeable Differences" or "JNDs," and are similar to decibels. The concept of a JND is based on the fact that a sensitive person can detect fine differences between two levels of stimulation, whereas an insensitive person cannot. Because differences of less than one JND are difficult to distinguish, one JND is the smallest difference presented to patients. Stimuli based on the JND scale can be used to test patients very efficiently and quickly, without compromising the significance of the clinical result.

Week 1, Week 2
Change in Median Cold Detection Threshold (CDT) Post-acupuncture Compared to Pre-acupuncture When the Ulnar Nerve is Treated
Time Frame: Week 1, Week 2
This is the mean change plus standard deviation in the sensory territory of the Median nerve when the Ulnar nerve was treated.
Week 1, Week 2
Change in Ulnar Cold Detection Threshold (CDT) Post-acupuncture Compared to Pre-acupuncture When the Ulnar Nerve is Treated
Time Frame: Week 1, Week 2
This is the mean plus standard deviation change in CDT in the sensory territory of the ulnar nerve when the ulnar nerve is treated.
Week 1, Week 2

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Actual)

May 1, 2021

Study Completion (Actual)

December 1, 2021

Study Registration Dates

First Submitted

August 14, 2016

First Submitted That Met QC Criteria

January 25, 2017

First Posted (Estimated)

January 30, 2017

Study Record Updates

Last Update Posted (Estimated)

October 9, 2023

Last Update Submitted That Met QC Criteria

October 5, 2023

Last Verified

October 1, 2023

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carpal Tunnel Syndrome

Clinical Trials on MAC acupuncture needles

Subscribe